| Exploring the diversity of the marine environment for new anti-cancer compounds DL Dayanidhi, BC Thomas, JS Osterberg, M Vuong, G Vargas, ... Frontiers in Marine Science 7, 614766, 2021 | 33 | 2021 |
| A precision medicine drug discovery pipeline identifies combined CDK2 and 9 inhibition as a novel therapeutic strategy in colorectal cancer JA Somarelli, RS Roghani, AS Moghaddam, BC Thomas, G Rupprecht, ... Molecular cancer therapeutics 19 (12), 2516-2527, 2020 | 18 | 2020 |
| Exploring the diversity of the marine environment for new anti-cancer compounds. Front DL Dayanidhi, BC Thomas, JS Osterberg, M Vuong, G Vargas, ... Mar. Sci 7 (614766), 10.3389, 2021 | 12 | 2021 |
| Convergent evolution of p38/MAPK activation in hormone resistant prostate cancer mediates pro-survival, immune evasive, and metastatic phenotypes KE Ware, S Gupta, J Eng, G Kemeny, BJ Puviindran, WC Foo, ... bioRxiv, 2020.04. 22.050385, 2020 | 8 | 2020 |
| A synthetic lethal screen for Snail-induced enzalutamide resistance identifies JAK/STAT signaling as a therapeutic vulnerability in prostate cancer KE Ware, BC Thomas, PD Olawuni, MU Sheth, N Hawkey, M Yeshwanth, ... Frontiers in Molecular Biosciences 10, 1104505, 2023 | 2 | 2023 |
| A precision medicine drug discovery pipeline to identify dual CDK2/9 inhibition as a novel treatment for colorectal cancer. R Salman Roghani, A Sanjari moghaddam, G Rupprecht, E Altunel, ... Journal of Clinical Oncology 38 (15_suppl), e16056-e16056, 2020 | 1 | 2020 |
| Utility of ClassDojo for Real-Time Formative Assessment of Professionalism in Pre-clerkship Medical Education J McAlister, B Thomas, JMM van de Ridder, V Rajput, K Bauckman Medical Science Educator 32 (2), 275-277, 2022 | | 2022 |
